The expression levels of HNRNPA2B1 and their association with the clinicopathological characteristics and prognosis in NSCLC were determined by RT-qPCR, Western blot, immunohistochemistry and TCGA dataset. This evidence concerns the gene HNRNPA2B1 and non-small cell lung carcinoma.